Not applicableNot Yet RecruitingNCT06651203
What this trial is testing
Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
Who this might be right for
Mycosis Fungoides/Sezary SyndromeCutaneous T Cell Lymphoma
Assistance Publique - Hôpitaux de Paris 460